Infinity Pharmaceuticals, Inc.

INFIQ · OTC
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Activities
Net Income-$44-$45-$40-$47
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$4$3$1$2
Change in WC-$1$2$1$1
Other Non-Cash-$1-$1$1$2
Operating Cash Flow-$42-$41-$36-$42
Investing Activities
PP&E Inv.-$0-$0-$0-$2
Net Acquisitions$0$0$0$0
Inv. Purchases-$16$0-$43-$42
Inv. Sales/Matur.$16$6$58$32
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0$5$15-$12
Financing Activities
Debt Repay.$0$0$20$0
Stock Issued$0$87$8$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$28
Financing Cash Flow$0$87$27$28
Forex Effect$0$0$0$0
Net Chg. in Cash-$42$52$6-$26
Supplemental Information
Beg. Cash$81$29$23$49
End Cash$38$81$29$23
Free Cash Flow-$42-$41-$36-$44